Colonoscopy screening: Innovative intervention point for tobacco cessation
Tobacco use remains the leading cause of preventable death and disease in the United States, with smoking contributing to 443,000 deaths annually. Smoking cessation can greatly reduce health risks and increase quality years of life. Tailored interventions in health care settings are recommended as part of the CDC's best practices for tobacco control. Data was collected as part of a Bankhead-Coley study assessing patients undergoing colorectal screenings about their expectations, concerns, understanding of the procedure and perceived health status. Persons waiting for colonoscopy screening were surveyed (n=1113). Differences between current smokers and nonsmokers were analyzed (one-way between subjects ANOVA). Results revealed poorer self-reported health by smokers compared to nonsmokers based on the following questions: days experiencing poor physical health (mean 9.1 vs. 5.4; p<.05), days experiencing poor mental health (mean 8.2 vs. 4.3; p<.05), and days in which pain influenced usual activities (mean 7.3 vs. 4.0; p<.05). Smokers are significantly more likely to report poorer health status on multiple factors compared to nonsmokers. Providing tailored cessation messages to smokers receiving colonoscopy screenings may be an effective intervention point.
Implementation of health education strategies, interventions and programs
Provision of health care to the public
Social and behavioral sciences
Identify differences in self reported health status among smokers, non smokers and former smokers.
List three benefits of smoking cessation.
Keyword(s): Tobacco, Smoking Cessation
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have worked in tobacco cessation and prevention both at the individual and community levels. I am currently a doctoral student in the Department of Behavioral Science and Community Health, College of Public Health and Health Professions at the University of Florida.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.